Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Currently, there are many players in this market. Shenzhen Hepalink, Pharma Action (Tönnies Group), Fengrun Biological, Nanjing King-friend, Hebei Changshan Biochemical and some others are playing important roles in Crude Heparin industry. The market is dispersed for now and is seeing to be more concentrated in the future.There are two different types of Crude Heparin. The market can be segmented into: Pig Intestine Mucosa Heparin, Bovine Heparin and Others. Pig Intestine Mucosa Heparin is almost the only used and efficient types and took 99.6% market share in 2018. By application, LMWH is the largest consumer group, with market share of 89% in 2018.Companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The total competition market for Crude Heparin will become more intense, while the market is going to be more concentrated in the future.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Crude Heparin market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Crude Heparin market. Detailed analysis of key players, along with key growth strategies adopted by Crude Heparin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Shenzhen Hepalink Pharmaceutical Group
Pharma Action (Tönnies Group)
Changzhou Qianhong Biopharma Co, Ltd
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Biopharma
Aspen Oss
Hepac (Darling Ingredients)
Yantai Dongcheng Biochemicals
Huaian MDC Pharmaceutical
By Type:
Pig Intestine Mucosa Heparin
Bovine Heparin
Others
By End-User:
UFH
LMWH
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Crude Heparin Market
-
1.3 Market Segment by Type
-
1.3.1 China Crude Heparin Market Size and Growth Rate of Pig Intestine Mucosa Heparin from 2016 to 2027
-
1.3.2 China Crude Heparin Market Size and Growth Rate of Bovine Heparin from 2016 to 2027
-
1.3.3 China Crude Heparin Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Crude Heparin Market Size and Growth Rate of UFH from 2016 to 2027
-
1.4.2 China Crude Heparin Market Size and Growth Rate of LMWH from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Crude Heparin Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Crude Heparin by Major Types
-
3.4.1 Market Size and Growth Rate of Pig Intestine Mucosa Heparin
-
3.4.2 Market Size and Growth Rate of Bovine Heparin
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Crude Heparin Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Crude Heparin by Major End-Users
-
4.4.1 Market Size and Growth Rate of Crude Heparin in UFH
-
4.4.2 Market Size and Growth Rate of Crude Heparin in LMWH
5 Market Analysis by Regions
-
5.1 China Crude Heparin Production Analysis by Regions
-
5.2 China Crude Heparin Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Crude Heparin Landscape Analysis
-
6.1 North China Crude Heparin Landscape Analysis by Major Types
-
6.2 North China Crude Heparin Landscape Analysis by Major End-Users
7 Central China Crude Heparin Landscape Analysis
-
7.1 Central China Crude Heparin Landscape Analysis by Major Types
-
7.2 Central China Crude Heparin Landscape Analysis by Major End-Users
8 South China Crude Heparin Landscape Analysis
-
8.1 South China Crude Heparin Landscape Analysis by Major Types
-
8.2 South China Crude Heparin Landscape Analysis by Major End-Users
9 East China Crude Heparin Landscape Analysis
-
9.1 East China Crude Heparin Landscape Analysis by Major Types
-
9.2 East China Crude Heparin Landscape Analysis by Major End-Users
10 Northeast China Crude Heparin Landscape Analysis
-
10.1 Northeast China Crude Heparin Landscape Analysis by Major Types
-
10.2 Northeast China Crude Heparin Landscape Analysis by Major End-Users
11 Southwest China Crude Heparin Landscape Analysis
-
11.1 Southwest China Crude Heparin Landscape Analysis by Major Types
-
11.2 Southwest China Crude Heparin Landscape Analysis by Major End-Users
12 Northwest China Crude Heparin Landscape Analysis
-
12.1 Northwest China Crude Heparin Landscape Analysis by Major Types
-
12.2 Northwest China Crude Heparin Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Shenzhen Hepalink Pharmaceutical Group
-
13.1.1 Shenzhen Hepalink Pharmaceutical Group Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pharma Action (Tönnies Group)
-
13.2.1 Pharma Action (Tönnies Group) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Changzhou Qianhong Biopharma Co, Ltd
-
13.3.1 Changzhou Qianhong Biopharma Co, Ltd Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Nanjing King-friend Biochemical Pharmaceutical
-
13.4.1 Nanjing King-friend Biochemical Pharmaceutical Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Hebei Changshan Biochemical Pharmaceutical
-
13.5.1 Hebei Changshan Biochemical Pharmaceutical Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Changzhou Qianhong Biopharma
-
13.6.1 Changzhou Qianhong Biopharma Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Aspen Oss
-
13.7.1 Aspen Oss Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Hepac (Darling Ingredients)
-
13.8.1 Hepac (Darling Ingredients) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Yantai Dongcheng Biochemicals
-
13.9.1 Yantai Dongcheng Biochemicals Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Huaian MDC Pharmaceutical
-
13.10.1 Huaian MDC Pharmaceutical Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Crude Heparin Market Size and Growth Rate of Pig Intestine Mucosa Heparin from 2016 to 2027
-
Figure China Crude Heparin Market Size and Growth Rate of Bovine Heparin from 2016 to 2027
-
Figure China Crude Heparin Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Crude Heparin Market Size and Growth Rate of UFH from 2016 to 2027
-
Figure China Crude Heparin Market Size and Growth Rate of LMWH from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Crude Heparin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Crude Heparin Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Crude Heparin
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Crude Heparin by Different Types from 2016 to 2027
-
Table Consumption Share of Crude Heparin by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Pig Intestine Mucosa Heparin
-
Figure Market Size and Growth Rate of Bovine Heparin
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Crude Heparin by Different End-Users from 2016 to 2027
-
Table Consumption Share of Crude Heparin by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of UFH
-
Figure Market Size and Growth Rate of LMWH
-
Table China Crude Heparin Production by Regions
-
Table China Crude Heparin Production Share by Regions
-
Figure China Crude Heparin Production Share by Regions in 2016
-
Figure China Crude Heparin Production Share by Regions in 2021
-
Figure China Crude Heparin Production Share by Regions in 2027
-
Table China Crude Heparin Consumption by Regions
-
Table China Crude Heparin Consumption Share by Regions
-
Figure China Crude Heparin Consumption Share by Regions in 2016
-
Figure China Crude Heparin Consumption Share by Regions in 2021
-
Figure China Crude Heparin Consumption Share by Regions in 2027
-
Table North China Crude Heparin Consumption by Types from 2016 to 2027
-
Table North China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure North China Crude Heparin Consumption Share by Types in 2016
-
Figure North China Crude Heparin Consumption Share by Types in 2021
-
Figure North China Crude Heparin Consumption Share by Types in 2027
-
Table North China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table North China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure North China Crude Heparin Consumption Share by End-Users in 2016
-
Figure North China Crude Heparin Consumption Share by End-Users in 2021
-
Figure North China Crude Heparin Consumption Share by End-Users in 2027
-
Table Central China Crude Heparin Consumption by Types from 2016 to 2027
-
Table Central China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure Central China Crude Heparin Consumption Share by Types in 2016
-
Figure Central China Crude Heparin Consumption Share by Types in 2021
-
Figure Central China Crude Heparin Consumption Share by Types in 2027
-
Table Central China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table Central China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Crude Heparin Consumption Share by End-Users in 2016
-
Figure Central China Crude Heparin Consumption Share by End-Users in 2021
-
Figure Central China Crude Heparin Consumption Share by End-Users in 2027
-
Table South China Crude Heparin Consumption by Types from 2016 to 2027
-
Table South China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure South China Crude Heparin Consumption Share by Types in 2016
-
Figure South China Crude Heparin Consumption Share by Types in 2021
-
Figure South China Crude Heparin Consumption Share by Types in 2027
-
Table South China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table South China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure South China Crude Heparin Consumption Share by End-Users in 2016
-
Figure South China Crude Heparin Consumption Share by End-Users in 2021
-
Figure South China Crude Heparin Consumption Share by End-Users in 2027
-
Table East China Crude Heparin Consumption by Types from 2016 to 2027
-
Table East China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure East China Crude Heparin Consumption Share by Types in 2016
-
Figure East China Crude Heparin Consumption Share by Types in 2021
-
Figure East China Crude Heparin Consumption Share by Types in 2027
-
Table East China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table East China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure East China Crude Heparin Consumption Share by End-Users in 2016
-
Figure East China Crude Heparin Consumption Share by End-Users in 2021
-
Figure East China Crude Heparin Consumption Share by End-Users in 2027
-
Table Northeast China Crude Heparin Consumption by Types from 2016 to 2027
-
Table Northeast China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Crude Heparin Consumption Share by Types in 2016
-
Figure Northeast China Crude Heparin Consumption Share by Types in 2021
-
Figure Northeast China Crude Heparin Consumption Share by Types in 2027
-
Table Northeast China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table Northeast China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Crude Heparin Consumption Share by End-Users in 2016
-
Figure Northeast China Crude Heparin Consumption Share by End-Users in 2021
-
Figure Northeast China Crude Heparin Consumption Share by End-Users in 2027
-
Table Southwest China Crude Heparin Consumption by Types from 2016 to 2027
-
Table Southwest China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Crude Heparin Consumption Share by Types in 2016
-
Figure Southwest China Crude Heparin Consumption Share by Types in 2021
-
Figure Southwest China Crude Heparin Consumption Share by Types in 2027
-
Table Southwest China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table Southwest China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Crude Heparin Consumption Share by End-Users in 2016
-
Figure Southwest China Crude Heparin Consumption Share by End-Users in 2021
-
Figure Southwest China Crude Heparin Consumption Share by End-Users in 2027
-
Table Northwest China Crude Heparin Consumption by Types from 2016 to 2027
-
Table Northwest China Crude Heparin Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Crude Heparin Consumption Share by Types in 2016
-
Figure Northwest China Crude Heparin Consumption Share by Types in 2021
-
Figure Northwest China Crude Heparin Consumption Share by Types in 2027
-
Table Northwest China Crude Heparin Consumption by End-Users from 2016 to 2027
-
Table Northwest China Crude Heparin Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Crude Heparin Consumption Share by End-Users in 2016
-
Figure Northwest China Crude Heparin Consumption Share by End-Users in 2021
-
Figure Northwest China Crude Heparin Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Shenzhen Hepalink Pharmaceutical Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen Hepalink Pharmaceutical Group
-
Figure Sales and Growth Rate Analysis of Shenzhen Hepalink Pharmaceutical Group
-
Figure Revenue and Market Share Analysis of Shenzhen Hepalink Pharmaceutical Group
-
Table Product and Service Introduction of Shenzhen Hepalink Pharmaceutical Group
-
Table Company Profile and Development Status of Pharma Action (Tönnies Group)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharma Action (Tönnies Group)
-
Figure Sales and Growth Rate Analysis of Pharma Action (Tönnies Group)
-
Figure Revenue and Market Share Analysis of Pharma Action (Tönnies Group)
-
Table Product and Service Introduction of Pharma Action (Tönnies Group)
-
Table Company Profile and Development Status of Changzhou Qianhong Biopharma Co, Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changzhou Qianhong Biopharma Co, Ltd
-
Figure Sales and Growth Rate Analysis of Changzhou Qianhong Biopharma Co, Ltd
-
Figure Revenue and Market Share Analysis of Changzhou Qianhong Biopharma Co, Ltd
-
Table Product and Service Introduction of Changzhou Qianhong Biopharma Co, Ltd
-
Table Company Profile and Development Status of Nanjing King-friend Biochemical Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanjing King-friend Biochemical Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Nanjing King-friend Biochemical Pharmaceutical
-
Figure Revenue and Market Share Analysis of Nanjing King-friend Biochemical Pharmaceutical
-
Table Product and Service Introduction of Nanjing King-friend Biochemical Pharmaceutical
-
Table Company Profile and Development Status of Hebei Changshan Biochemical Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hebei Changshan Biochemical Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Hebei Changshan Biochemical Pharmaceutical
-
Figure Revenue and Market Share Analysis of Hebei Changshan Biochemical Pharmaceutical
-
Table Product and Service Introduction of Hebei Changshan Biochemical Pharmaceutical
-
Table Company Profile and Development Status of Changzhou Qianhong Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changzhou Qianhong Biopharma
-
Figure Sales and Growth Rate Analysis of Changzhou Qianhong Biopharma
-
Figure Revenue and Market Share Analysis of Changzhou Qianhong Biopharma
-
Table Product and Service Introduction of Changzhou Qianhong Biopharma
-
Table Company Profile and Development Status of Aspen Oss
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen Oss
-
Figure Sales and Growth Rate Analysis of Aspen Oss
-
Figure Revenue and Market Share Analysis of Aspen Oss
-
Table Product and Service Introduction of Aspen Oss
-
Table Company Profile and Development Status of Hepac (Darling Ingredients)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hepac (Darling Ingredients)
-
Figure Sales and Growth Rate Analysis of Hepac (Darling Ingredients)
-
Figure Revenue and Market Share Analysis of Hepac (Darling Ingredients)
-
Table Product and Service Introduction of Hepac (Darling Ingredients)
-
Table Company Profile and Development Status of Yantai Dongcheng Biochemicals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yantai Dongcheng Biochemicals
-
Figure Sales and Growth Rate Analysis of Yantai Dongcheng Biochemicals
-
Figure Revenue and Market Share Analysis of Yantai Dongcheng Biochemicals
-
Table Product and Service Introduction of Yantai Dongcheng Biochemicals
-
Table Company Profile and Development Status of Huaian MDC Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Huaian MDC Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Huaian MDC Pharmaceutical
-
Figure Revenue and Market Share Analysis of Huaian MDC Pharmaceutical
-
Table Product and Service Introduction of Huaian MDC Pharmaceutical
-
